Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

Yamanaka, Koji, Chun, Seung Joo, Boillee, Severine, Fujimori-Tonou, Noriko, Yamashita, Hirofumi, Gutmann, David H, Takahashi, Ryosuke, Misawa, Hidemi, Cleveland, Don W·2008·Nature Neuroscience
DOI 10.1038/nn2047

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Mediating Effect of Investment Decisions between Overconfidence Heuristic and Financial-Performance of Small, and Medium Enterprises in Nairobi, Kenya
    Alex Koecha, Josphat Cheboia, Naomi Koskea · 2020 · Journal of Business Management and Economic Research
  2. The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases?
    Lynette M. Bustos, Rita Sattler · 2023 · Frontiers in Molecular Medicine
  3. Multiple Factors Influence the Incubation Period of ALS Prion-like Transmission in SOD1 Transgenic Mice
    Jacob I. Ayers, Guilian M. Xu, Qing Lu, Kristy D. Dillon, Susan Fromholt, David Borchelt · 2023 · Viruses
  4. EphrinB2 knockdown in cervical spinal cord preserves diaphragm innervation in a mutant SOD1 mouse model of ALS
    Mark W. Urban, Brittany A. Charsar, Nicolette M. Heinsinger, Shashirekha S. Markandaiah, Lindsay Sprimont, Wei Zhou, Eric V. Brown, Nathan T. Henderson, Samantha J. Thomas, Biswarup Ghosh et al. · 2024 · eLife
  5. Stage-dependent efficacy of short-chain fatty acids in amyotrophic lateral sclerosis: Insights into autophagy and neuroprotection
    Zikai Xin, Cheng Xin, Jia Huo, Qi Liu, Hui Dong, Xin Li, Yaling Liu, Rui Li · 2025 · Life Sciences
  6. MiRNA-Mediated Regulation of S100B: A Review
    Animesh Dali, Suhana Basnyat, Rachel Delancey, Nipun Chopra · 2025 · NeuroSci
  7. Neurotrophic Therapy for ALS/MND
    Mary‐Louise Rogers · 2014 · Springer eBooks
  8. New frontiers in human cell biology and medicine: Can pluripotent stem cells deliver?
    Lawrence S.B. Goldstein · 2012 · The Journal of Cell Biology
  9. Um Anjo para ELA: Arquitetura Baseada em Visão Computacional Aplicada ao Monitoramento On-Line de Parâmetros Respiratórios de Pacientes com Esclerose Lateral Amiotrófica (ELA) em Ambiente Hospitalar
    Gustavo Henrique Souto da Silva, Antônio Higor Freire de Morais, Ricardo Alexsandro de Medeiros Valentim, Rummenigge Rudson Dantas, Leila Raulino Câmara Cavalcanti, Mário Emílio Teixeira Dourado Júnior · 2013 · Research on Biomedical Engineering
  10. Astrocyte Responses to Central Nervous System Injury and Disease
    Michael V. Sofroniew · 2012 · Oxford University Press eBooks
  11. Astrocytes in Pathogenesis of ALS Disease and Potential Translation into Clinic
    Michal Izrael, Shalom Guy Slutsky, Joseph Itskovitz‐Eldor, Revel Michel · 2018 · InTech eBooks
  12. Excitotoxicity and Amyotrophic Lateral Sclerosis
    Kim A. Staats, Ludo Van Den Bosch · 2014 · Springer eBooks
  13. Correction: Motoneuron Differentiation of Induced Pluripotent Stem Cells from SOD1G93A Mice
    Xiaoli Yao, Chenghui Ye, Qiang Liu, Jian‐Bo Wan, Jun Zhen, Andy Peng Xiang, Weiqiang Li, Yitao Wang, Huangxing Su, Xi-Lin Lu · 2013 · PLoS ONE
  14. Connexin 43 hemichannels mediate spatial and temporal disease spread in ALS
    Akshata A. Almad, Arens Taga, Jessica Joseph, Connor Welsh, Aneesh G. Patankar, Sarah K. Gross, Jean‐Philippe Richard, Aayush Pokharel, Mauricio A. Lillo, Raha Maryam Dastgheyb et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Novel morphological glial alterations in the spectrum of prion disease types: A focus on common findings.
    Garcés, Moisés, Guijarro, Isabel M., Ritchie, Diane L., Badiola, Juan J., Monzón, Marta · 2021 · Pathogens
  16. ALS-like pathology diminishes swelling of spinal astrocytes in the SOD1 animal model
    Tereza Filipi, Jana Turečková, Ondřej Vaňátko, Martina Chmelová, Monika Kubiskova, Natalia Sirotova, Stanislava Matějková, Lýdia Vargová, Miroslava Anděrová · 2024 · Frontiers in Cellular Neuroscience
  17. Targeting Astrocytic Connexin 43 Mitigates Glutamate-Driven Motor Neuron Stress in Late-Onset Spinal Muscular Atrophy
    Schahin Salmanian, Linda-Isabell Schmitt, Kai Christine Liebig, Stefanie Hezel, Andreas Roos, Ulrike Schara, Christoph Kleinschnitz, Markus Leo, Tim Hagenacker · 2025 · Cells
  18. Non-cell autonomous autophagy in amyotrophic lateral sclerosis: A new promising target?
    Francesca Rosso, Rocio Magdalena, Carola Torazza, Francesca Bacchetti, Marco Milanese, Angelo Poletti, Giambattista Bonanno, Riccardo Cristofani, Tiziana Bonifacino · 2025 · Neurobiology of Disease
  19. Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes
    Daniel Esteve, Mariana Bresque, Daniel Ohiokhai Okhuevbie, Sandhya Ramachandran, Mariana Pehar, Marcelo R. Vargas · 2026 · Glia
  20. An emergent disease-associated motor neuron state precedes cell death in ALS
    Olivia Gautier, Jacob A. Blum, Thao P. Nguyen, Shaolong Cao, Sandy L. Klemm, Mai Yamakawa, Dann Huh, Jessica A. Hurt, Nasa Sinnott-Armstrong, Yi Zeng et al. · 2026 · Cell
  21. The Use of Human Samples to Study Familial and Sporadic Amyotrophic Lateral Sclerosis: New Frontiers and Challenges
    Laura Ferraiuolo, Kathrin Meyer, Brian K. Kaspar · 2013 · InTech eBooks
  22. Glial Cells as Therapeutic Targets for ALS
    Miller Amberber Amanda, Nicholas J. C. King · 2012 · InTech eBooks
  23. Motoneuron Diseases
    Francesco Lotti, Serge Przedborski · 2022 · Advances in neurobiology
  24. Biological aspects of nitrogen heterocycles for amyotrophic lateral sclerosis
    Ravichandran Manjupriya, Kamalanathan Pouthika, Gunabalan Madhumitha, Selvaraj Mohana Roopan · 2022 · Applied Microbiology and Biotechnology
  25. Transgenesis in Drug Discovery: Enhancing Target Identification and Validation
    Rumela Mete, Sourav Das, Arindam Saha, Sukanta Roy, Smritilekha Mondal, Anirbandeep Bose, Biswajit Basu, Gehan M. Elossaily, Bhupendra Gopalbhai Prajapati · 2025 · Molecular Biotechnology
  26. Kv3 channel agonist ameliorates the phenotype of a mouse model of amyotrophic lateral sclerosis
    Manuela Marabita, Caterina Marchioretti, Aishwarya Aravamudhan, Simona Zito, Antonella Falconieri, Emanuela Zuccaro, Roberta Andreotti, Lisa Gambarotto, Samuele Metti, Marika Tonellato et al. · 2025 · Acta Neuropathologica Communications
  27. Amyotrophic Lateral Sclerosis: Fuel for the Corticofugal Feud
    Brian J. Wainger, Robert H. Brown · 2020 · Annals of Neurology
  28. Stem Cell Application for Amyotrophic Lateral Sclerosis: Growth Factor Delivery and Cell Therapy
    Masatoshi Suzuki, Chak Foon Tso, G. Michael · 2012 · InTech eBooks
  29. Treatmemt Options in Motor Neuron Disease: Amyotrophic Lateral Schlerosis and Spinal Muscular Atrophy
    James JM Loan, Stuart D. Connolly, David Z. Haunschmidt, Stephen B. Bell, Sophie A. Clarke, Joanne Kelly, Ailsa J. Oswald, Valerie Rae · 2012 · Biochemistry and Molecular Biology Education
  30. Glial Communication via Gap Junction in Neuroinflammation
    Hideyuki Takeuchi · 2013 · Advances in neurobiology
  31. Amyotrophic lateral sclerosis with the SOD1 mutations
    Masashi Aoki, Hitoshi Warita, Yasuto Itoyama · 2008 · Rinsho Shinkeigaku
  32. Neurocristopathies: Role of Glial Cells, Genetic Basis and Relevance of Brain Imaging for Diagnosis
    Miguel Romero, Carlos de Cabo · 2012 · InTech eBooks
  33. Role of Cysteine Residue of Mutant Cu, Zn‐Superoxide Dismutase (SOD1) in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)
    Seiichi Nagano, Toshiyuki Araki · 2016 · InTech eBooks
  34. Essential Requirements for Setting Up a Stem Cell Laboratory
    Philip H. Schwartz, Robin L. Wesselschmidt · 2017 · Neuromethods
  35. Contribution of Aberrant Astrocytes to Motor Neuron Damage and Death in the SOD1G93A Rat Experimental Model of ALS
    Gabriel Otero Damianovich, Olga Cristina Parada, Pablo Díaz‐Amarilla, Eugenia Isasi, Carmen Isabel Bolatto Pereira, Silvia Olivera‐Bravo · 2019 · IntechOpen eBooks
  36. Neuron–Astrocyte Interactions in Neuroinflammation
    Jasna Križ · 2013 · Advances in neurobiology
  37. Neuroinflammation in Neurological Disorders
    Jun‐ichi Kira · 2013 · Advances in neurobiology
  38. The role of astrocytes with genetic mutations linked to amyotrophic lateral sclerosis
    David Brash-Arias, Gonzálo Emiliano Aranda-Abreu, Fausto Rojas-Durán, María Elena Hernández‐Aguilar, María Rebeca Toledo‐Cárdenas, César Antonio Pérez-Estudillo, Arturo Ortega, Donají Chi-Castañeda · 2023 · Neurology Perspectives
  39. Morphological and molecular changes in the Harderian gland of streptozotocin‐induced diabetic rats
    Maria Zelinda Romano, Serena Boccella, Massimo Venditti, Sabatino Maione, Sergio Minucci · 2023 · Journal of Experimental Zoology Part A Ecological and Integrative Physiology
  40. Mislocalization, aggregation formation and defect in proteolysis in ALS
    Atsushi Tsubota, Hidenori Ichijo, Kengo Homma · 2016 · AIMS molecular science
  41. Exploring motor neuron degeneration in ALS - prevention by glycoursodeoxycholic acid and signaling to microglia
    Joana Carolina Marinho Cunha · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  42. Neuroimmunology of Amyotrophic Lateral Sclerosis
    J. Henkel-Tigges, David R. Beers, Weihua Zhao, Stanley H. Appel · 2014
  43. Pharmakologische Inhibition von Rho-Kinase im Mausmodell der Amyotrophen Lateralsklerose
    René Günther · 2015 · eDiss (Georg-August-Universität Göttingen)
  44. Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor
    Masashi Aoki, Hitoshi Warita, Naoki Suzuki, Yasuto Itoyama · 2009 · Rinsho Shinkeigaku
  45. Zebrafish C9orf72 loss-of-function models of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    Natalie Rounding · 2018 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  46. Exosome-shuttled miRNAs contribute to the modulation of the neuroinflammatory microglia phenotype by mesenchymal stem cells. Implication for amyotrophic lateral sclerosis
    Debora Giunti, Chiara Marini, Benedetta Parodi, Cesare Usai, Marco Milanese, Giambattista Bonanno, Nicole Kerlero de Rosbo, Antonio Uccelli · 2019
  47. Dysregulated expanded endocannabinoid system as therapeutic targets of amyotrophic lateral sclerosis
    Daisuke Ito, Madoka Iida, Yohei Iguchi, Atsushi Hashizume, Shinichiro Yamada, Yoshiyuki Kishimoto, Shota Komori, Teppei Shimamura, Yuto Takemoto, Masahiro Nakatochi et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Glial state changes and neuroinflammatory RIPK1 signaling are a key feature of ALS pathogenesis
    Matija Zelic, Anna S. Blazier, Fabrizio Pontarelli, Michael J. LaMorte, Jeremy Y. Huang, Ozge E. Tasdemir-Yilmaz, Yi Ren, Sean K. Ryan, Pavithra Krishnaswami, Mikhail N. Levit et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death
    Pablo Martínez, Mónica Silva, Sebastián Abarzúa, María Florencia Tevy, Enrique Jaimovich, Martha Constantine‐Paton, Fernando J. Bustos, Brigitte van Zundert · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  50. An emergent disease-associated motor neuron state precedes cell death in a mouse model of ALS
    Olivia Gautier, Jacob A. Blum, Thao P. Nguyen, Sandy L. Klemm, Mai Yamakawa, Nasa Sinnott-Armstrong, Yi Zeng, Chung-ha O. Davis, Juliane Bombosch, Lisa Nakayama et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  51. miR-146a is a pleiotropic regulator of motor neuron degeneration
    Dylan A. Galloway, Hunter L. Patterson, Mariah L. Hoye, Tao Shen, Mark Shabsovich, Kathleen M. Schoch, Cindy V. Ly, Jonathan S. Mill · 2026 · Proceedings of the National Academy of Sciences
  52. Glutamate-Glutamine metabolism and transport, implications in Parkinson’s disease
    Ragini Raghu, Subashchandrabose Chinnathambi · 2026 · International review of neurobiology
  53. The Glutamate–Glutathione axis in neuropsychiatric disorders and cancer: From shared mechanisms to non-invasive biomarkers
    Rui Wang, Yanfei Li, Dafa Shi, Hongying Huang, Zhongruowen Ren, Yuxi Ge, Yongmin Chang, Gen Yan · 2026 · Redox Biology
  54. Fos regulates age-dependent neuroinflammation in a VAPP58S model of amyotrophic lateral sclerosis
    Namrata Pramod Kulkarni, Aparna Thulasidharan, Amarendranath Soory, Pulkit Goel, Sanhita Sarkar, Vidyadheesh Kelkar, Girish S. Ratnaparkhi · 2026 · Disease Models & Mechanisms
  55. Immune checkpoint LAG-3 governs stage-dependent and disease-associated microglial modules in ALS model mice
    Yuta Morisaki, Nanaka Nomura, Motoki Ohshima, Miruto Matsuda, Okiru Komine, Takashi Okuda, Koji Yamanaka, Hidemi Misawa · 2026 · Journal of Neuroinflammation
  56. Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model
    Fang Wan, Jinchen He, Hong Ma, Debora Pires-Ferreira, Veena Kumanan, Ji Sun Lee, Xiupeng Chen, Ran He, Qin Su, T. F. Gallagher et al. · 2026 · Nature Communications
  57. Unraveling the molecular mechanism underlying ALS-linked astrocyte toxicity for motor neurons
    Burcin Ikiz · 2013
  58. Reactive Oxygen and Nitrogen Species – A Driving Force in Amyotrophic Lateral Sclerosis
    J. Henkel-Tigges, David R. Beers, Weihua Zhao, Stanley H. Appel · 2014 · Springer eBooks
  59. Heterogeneous Nuclear Ribonucleoproteins In Amyotrophic Lateral Sclerosis: What Do We Know?
    Diane Moujalled, Anthony Robert White · 2014 · Future Neurology
  60. Recent Advances in ALS Research: Perspectives for Personalized Clinical Application
    Chen Benkler, Daniel Offen, Eldad Melamed, Tamar Amit, Silvia A. Mandel, Moussa B. H. Youdim, Orly Weinreb · 2012 · Advances in predictive, preventive and personalised medicine
  61. The fate of injured motor neurons and the behavior of surrounding glial cells
    Hiroshi Kiyama · 2012 · Rinsho Shinkeigaku
  62. Animal Models of Amyotrophic Lateral Sclerosis
    Ludo Van Den Bosch · 2010 · Neuromethods
  63. Motor Neuron Differentiation from Pluripotent Stem Cells: Development of the Technique, Synopsis of Protocols, and Summary of Current Applications
    Helen C. Miranda, Albert R. La Spada · 2016 · Springer eBooks
  64. An Autopsy Case of Amyotrophic Lateral Sclerosis with Neuroinflammatory change
    Seung Hyun Ha, Won‐Ki Baek, Ho Kim, Min‐Young Noh, Se Jin Hwang, Seung Hyun Kim · 2012 · Journal of the Korean Neurological Association
  65. Non-cell Autonomous Degeneration
    Sarah Elizabeth Smith, Azad Bonni · 2018 · Elsevier eBooks
  66. Astrocytes play a crucial role in the formation and evolution of MS lesions – No
    Nicole Kerlero de Rosbo · 2018 · Multiple Sclerosis Journal
  67. Advances in the Research of Astrocyte Function in Neural Regeneration
    Madhulika Srikanth, Li Yao, Ramazan Asmatulu · 2018 · Springer eBooks
  68. Genetic model of motor neuron disease in B6SJL-Tg mice: new data on the dynamics of motor symptoms and immunohistochemical manifestations of the neurodegenerative process
    Alla V. Stavrovskaya, Д. Н. Воронков, E. A. Artyomova, Boris V. Belugin, М. М. Шмаров, Nina G. Yamshikova, Анастасия Сергеевна Гущина, Artyom S. Olshansky, Boris S. Naroditsky, Sergey Nikolaevich Illarioshkin · 2020 · Neuromuscular Diseases
  69. Inflammation and the Pathophysiology of Astrocytes in Neurodegenerative Diseases
    Gordon P. Meares, Etty N. Benveniste · 2014 · Springer eBooks
  70. Glial Cells
    Teresa Faria Pais · 2016 · Compendium of Inflammatory Diseases
  71. Animal models for neurodegenerative disorders
    Koji Yamanaka · 2020 · Elsevier eBooks
  72. Modest Reduction in CAG Repeat Length Rescues Motor Deficits but Not Purkinje Cell Pathology and Gliosis in Spinocerebellar Ataxia Type 1 Mice
    Stephen Gilliat, Juao‐Guilherme S Rosa, Genevieve Benjamin, Kaelin Sbrocco, Wensheng Lin, Marija Cvetanović · 2023 · Neuroglia
  73. Neuroinflammation in neurodegenerative disease.
    Koji Yamanaka · 2023 · PubMed Central
  74. Toxicity and chemical compounds of Piper aduncum fruit extract against storage pest Sitophilus oryzae and Callosobruchus maculatus
    Rohimatun Rohimatun, Mahindra Dewi Nur Aisyah, Lindung Tri Puspasari, Devi Rusmin · 2023 · IOP Conference Series Earth and Environmental Science
  75. Astrocyte-Neuron Interactions Contributing to Amyotrophic Lateral Sclerosis Progression
    Brigid K. Jensen · 2024 · Advances in neurobiology
  76. Amyotrophic Lateral Sclerosis: A Glial Perspective
    Chiara F. Valori, Liliana Brambilla, Daniela Rossi · 2014 · Springer eBooks
  77. Of fish, flies, worms and men: Powerful approaches to neuropsychiatric disease using genetic models
    Edward A. Burton, Michael J. Palladino · 2010 · Neurobiology of Disease
  78. HSF Inhibits the Progression of Age-Related Neurodegenerative Diseases
    Naohide Kondo, Masahisa Katsuno, Yuichi Riku, Gen Sobue · 2016 · Springer eBooks
  79. Glial pathology in amyotrophic lateral sclerosis
    Koji Yamanaka · 2011 · Rinsho Shinkeigaku
  80. Genetic Factors in Environmentally Induced Disease
    J. Timothy Greenamyre, Paul J. Barrett · 2015 · Elsevier eBooks
  81. Content Personalized Recommendation Engine to Support an Informal Learning Environment in the Health Context
    Alisson Alan Lima da Costa, Francisco Milton Mendes Neto, Ênio Lopes Sombra, Jonathan Darlan Cunegundes Moreira, Rafael Castro de Souza, Jerffeson Gomes Dutra · 2016 · Advances in game-based learning book series
  82. Clinical Features, Pathogenesis, and Therapy for ALS
    Koji Abe · 2012 · Spinal Surgery
  83. Point-Of-Care Stem Cell Therapy (POCST): Multisite transplantation of autologous bone marrow-derived mononuclear cells in 85 patients with Amyotrophic Lateral Sclerosis improves survival
    Francisco Ruiz-Navarro · 2017 · Journal of Stem Cell Research & Therapeutics
  84. Dark side of astrocytes: Toxic, reactive astrocytes induced by activated microglia
    Koji Yamanaka · 2017 · Clinical and Experimental Neuroimmunology
  85. Glutamate in Amyotrophic Lateral Sclerosis: An Ageless Contestant
    Alida Spalloni, Michele Nutini, Patrizia Longone · 2018 · Springer eBooks
  86. Neuroinflammation in dementia and neurodegeneration
    Koji Yamanaka · 2018 · Clinical and Experimental Neuroimmunology
  87. Modulation of Cellular Circadian Rhythms by Secondary Metabolites of Lichens
    Soumi Srimani, Cosima Xenia Schmidt, María Pilar Gómez-Serranillos, Henrik Oster, Pradeep Kumar Divakar · 2022 · Frontiers in Cellular Neuroscience
  88. Studies on Semaphorin 3A in the Neuromuscular
    Prof. Dr. P. Heutink, Dr. E. Hol, Dr. R. J. Pasterkamp, Van Leersum Fonds, Lundbeck Bv, Cover Tri, Tam Vo, Book Design Koen Bossers, Tri Tam Vo · 2011 · Data Archiving and Networked Services (DANS)
  89. Caregiver Religiosity, Spirituality, and Positive Emotion as Predictors of Psychological Well-being in Amyotrophic Lateral Sclerosis Patients
    Andrea Beth Weller · 2009 · Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
  90. Using patient-derived cell models to investigate the role of misfolded SOD1 in ALS
    Elin Forsgren · 2017 · DiVA at Umeå University (Umeå University)
  91. EphrinB2 knockdown in cervical spinal cord preserves diaphragm innervation in a mutant SOD1 mouse model of ALS
    Mark W. Urban, Brittany A. Charsar, Nicolette M. Heinsinger, Shashirekha S. Markandaiah, Lindsay Sprimont, Wei Zhou, Eric V. Brown, Nathan T. Henderson, Samantha J. Thomas, Biswarup Ghosh et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  92. TNFα hinders FGF4 efficacy to mitigate ALS astrocyte dysfunction and cGAS-STING pathway-induced innate immune reactivity
    Erika Velásquez, Ekaterina Savchenko, Sara Marmolejo-Martínez-Artesero, Désiré Challuau, Aline Aebi, Yuriy Pomeshchik, Nuno Jorge Lamas, Mauno Vihinen, Melinda Rezeli, Bernard Laurent Schneider et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  93. A structure-guided antibody detects SOD1 oligomers in diverse ALS genotypes
    Smriti Sangwan, Hannah E. Rieder, Destaye M. Moore, Négar Khanlou, Bennett G. Novitch, Mark Geisberg, David S Eisenberg · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Modulation of the JAK2/STAT3 pathway in vivo : understanding reactive astrocyte functional features and contribution to neurodegenerative diseases
    Lucile Ben Haim · 2014 · theses.fr (ABES)
  95. Misfolded superoxide dismutase-1 in sporadic and familial Amyotrophic Lateral Sclerosis
    Karin Forsberg · 2011 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  96. Mutations in PI(3,5)P2 Signaling and Neurodegeneration in Mouse and Human.
    Clement Y. Chow · 2008 · Deep Blue (University of Michigan)
  97. Using the natural resistance of motor neuron subpopulations to identify therapeutic targets in amyotrophic lateral sclerosis
    Krista J. Spiller · 2014
  98. The Role of Schwann Cell Mitochondrial Metabolism in Schwann Cell Biology and Axonal Survival
    Andreu Viader · 2011 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  99. The Astrocytic Contribution in ALS: Inflammation and Excitotoxicity
    Kim A. Staats, Ludo Van Den Bosch · 2012 · InTech eBooks
  100. Molecular and Electrical Abnormalities in the Mouse Model of Amyotrophic Lateral Sclerosis
    A. Katharina, Sherif M., C.J. Heckm · 2012 · InTech eBooks